We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+1.72%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$780M
AUM Growth
+$181M
Cap. Flow
+$169M
Cap. Flow %
21.69%
Top 10 Hldgs %
29%
Holding
5,646
New
1,097
Increased
1,409
Reduced
2,025
Closed
1,047

Sector Composition

Rank Sector Weight
1 Financials 7.89%
2 Industrials 5.11%
3 Technology 4.56%
4 Energy 4.21%
5 Healthcare 3.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBRL icon
1001
Cracker Barrel
CBRL
$1.3B
$57K 0.01%
+587
New +$59.2K
OMAB icon
1002
Grupo Aeroportuario Centro Norte
OMAB
$5.37B
$57K 0.01%
+1,981
New +$51.8K
SAAS
1003
DELISTED
inContact, Inc.
SAAS
$57K 0.01%
5,957
+5,557
+1,389% +$51.1K
STSA
1004
DELISTED
STERLING FINL CORP (WA) COM NEW
STSA
$57K 0.01%
+1,709
New +$55.3K
TNK icon
1005
Teekay Tankers
TNK
$2.67B
$56K 0.01%
1,988
+1,973
+13,153% +$61.8K
TEN
1006
Tsakos Energy Navigation Ltd
TEN
$1.18B
$56K 0.01%
1,445
+641
+80% +$22.4K
ZVO
1007
DELISTED
Zovio Inc. Common Stock
ZVO
$56K 0.01%
3,762
+962
+34% +$16.6K
VWTR
1008
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
$56K 0.01%
+2,148
New +$53K
PTVCB
1009
DELISTED
Protective Insurance Corporation Class B Common Stock
PTVCB
$56K 0.01%
+2,101
New +$53.6K
ARRY
1010
DELISTED
Array Biopharma Inc
ARRY
$56K 0.01%
11,891
+4,139
+53% +$20.8K
ABBV icon
1011
AbbVie
ABBV
$431B
$55K 0.01%
1,074
+568
+112% +$28.7K
BBW icon
1012
Build-A-Bear
BBW
$435M
$55K 0.01%
5,700
+5,620
+7,025% +$48.2K
CLDX icon
1013
Celldex Therapeutics
CLDX
$3.26B
$55K 0.01%
208
+63
+43% +$24.1K
EQNR icon
1014
Equinor
EQNR
$93.7B
$55K 0.01%
1,939
+1,387
+251% +$35.8K
FLC
1015
Flaherty & Crumrine Total Return Fund
FLC
$175M
$55K 0.01%
+2,800
New +$53.6K
HQH
1016
abrdn Healthcare Investors
HQH
$1.31B
$55K 0.01%
2,075
+1,410
+212% +$39.2K
RGLS
1017
DELISTED
Regulus Therapeutics
RGLS
$55K 0.01%
51
+48
+1,600% +$53.2K
VET icon
1018
Vermilion Energy
VET
$1.68B
$55K 0.01%
800
-863
-52% -$49.5K
GPT
1019
DELISTED
Gramercy Property Trust
GPT
$55K 0.01%
3,582
-1,685
-32% -$28.7K
VR
1020
DELISTED
Validus Hold Ltd
VR
$55K 0.01%
1,451
+1,163
+404% +$43.1K
BWLD
1021
DELISTED
Buffalo Wild Wings, Inc.
BWLD
$55K 0.01%
370
-74
-17% -$10.5K
ALJ
1022
DELISTED
Alon USA Energy Inc
ALJ
$55K 0.01%
3,625
-9,843
-73% -$149K
FREE
1023
DELISTED
FREESEAS INC SHS NEW APR 2016 (MHL)
FREE
0
SIMG
1024
DELISTED
SILICON IMAGE INC
SIMG
$55K 0.01%
7,940
+6,340
+396% +$39.1K
RESI
1025
DELISTED
Front Yard Residential Corporation Common Stock
RESI
$55K 0.01%
1,747
+1,181
+209% +$35.7K

Similar funds

Tower Research Capital (TRC)'s Q1 2014 Portfolio in Review

As of Q1 2014, Tower Research Capital (TRC) held 5,646 positions worth $780M, up 30% from $599M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $169M of net new capital in Q1 2014, opening 1,097 new positions and adding to 1,409 existing holdings. Its largest new stake was iShares US Real Estate ETF: 131,900 shares worth $8.93M.

By sector, the portfolio is most concentrated in Financials at 7.9% of assets, down from 8% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $40.7M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2014 buy was iShares US Real Estate ETF: 131,900 shares worth $8.93M.
  • Tower Research Capital (TRC) added most to Invesco QQQ Trust in Q1 2014, an estimated $111M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2014 reduction was iShares Russell 2000 ETF, cutting an estimated $40.7M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Dow Jones Industrial Average ETF Trust in Q1 2014, selling an estimated $8.86M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $780M portfolio in Q1 2014.
  • Tower Research Capital (TRC) opened 1,097 new positions and closed 1,047 in Q1 2014.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $780M.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2014, filed 2 May 2014.